UNSPSC 85253402: Diagnosis of intraductal carcinoma in situ

This classification denotes the group of activities that yields a diagnosis of Intraductal carcinoma in situ. Intraductal carcinoma in situ is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code D05. 1

UNSPSC 85253402 Diagnosis of intraductal carcinoma in situ is a Commodity code, but the recent state and local procurement activity tagged under it does not align with diagnostic pathology for breast cancer. The code itself describes laboratory or clinical diagnosis of intraductal carcinoma in situ (DCIS), yet the three most recent opportunities solicited by state and local bodies — a diagnostic imaging PACS system, special education contracted services, and temporary health professional staffing — fall outside this scope. The source contains no recent solicitations for pathology diagnosis services, pathology information systems, or DCIS screening and diagnostic work under this code.

The code shows little relevant recent activity. Issuing bodies posting under this UNSPSC appear to include county health systems and hospital operators, school districts, and regional health authorities, but their tagged opportunities do not reflect the actual procurement of diagnostic services for intraductal carcinoma. The geographic spread indicated by the three opportunities spans California (San Mateo County, Santa Clara County) and Texas (Tarrant County), yet none of these solicitations addresses the code's nominal scope of DCIS diagnosis. A business development professional evaluating this code should verify whether the code is being misapplied in state and local procurement systems or whether demand for DCIS diagnostic services under this UNSPSC is currently inactive across monitored jurisdictions.